Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs
By
Kyle Umipig
Kettled twice. Extra chewy, extra trustworthy.
Summary
Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The company's MUXBODY technology enables engineering of multiple therapeutic modalities into a single molecule to target complex diseases from multiple angles simultaneously. Co-founder Willie Xiang highlighted the company's flexible hub-and-spoke structure for efficiently translating diverse programs into clinical development. The funding reflects growing investor interest in multi-target biologic approaches to complex diseases.
Key quotes
· 2 pulledOur platform gives us the ability to engineer multiple modalities into a single molecule to target a variety of disease mechanisms.
Our flexible hub-and-spoke company structure lets us efficiently translate our diverse MUXBODY programs into the clinic.
You might also wanna read
Custom Gene Synthesis Service Market Projected to Reach $5.3 Billion by 2035 at 8.2% CAGR
The Custom Gene Synthesis Service Market is projected to grow from USD 2.41 billion to USD 5.3 billion by 2035, at a CAGR of 8.2% during 202
wiseguyreports.com·4d ago
OpenAI Launches GPT-Rosalind: A Frontier Reasoning Model for Life Sciences Research
OpenAI has introduced GPT-Rosalind, a frontier reasoning model specifically designed for life sciences research. The model is optimized for
openai.com·1mo ago
Tetractys: Graph-Based AI for Biomanufacturing Process Optimization
Tetractys is a graph-based AI system designed for biomanufacturing that provides real-time management of microbiological systems. The pre-tr
Product Hunt·1mo ago
Cortical Labs: Developing Biological Intelligence Systems Using Living Neurons
The article appears to be about Cortical Labs, a company working on biological computing systems that combine living brain cells with comput
corticallabs.com·2mo ago
OpenAI and Retro Biosciences Develop AI Model That Achieves 50x Improvement in Stem Cell Reprogramming
OpenAI collaborated with Retro Biosciences to develop GPT-4b micro, a specialized AI model for protein engineering. The AI-designed proteins
openai.com·9mo ago
Google's Debug program seeks EPA permit to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·2h ago